Search hospitals > Pennsylvania > York
WellSpan Health-York Cancer Center
Claim this profileYork, Pennsylvania 17403
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
129 reported clinical trials
9 medical researchers
Summary
WellSpan Health-York Cancer Center is a medical facility located in York, Pennsylvania. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. WellSpan Health-York Cancer Center is involved with conducting 129 clinical trials across 170 conditions. There are 9 research doctors associated with this hospital, such as Chanh T. Huynh, Amit B. Shah, Dan Sotirescu, and Joseph Kannarkatt.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
Chanh T. HuynhAdams Cancer Center1 year of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
20 reported clinical trials
37 drugs studied
Amit B. ShahWellSpan Health-York Cancer Center3 years of reported clinical research
Studies Prostate Cancer
Studies Small Cell Lung Cancer
21 reported clinical trials
63 drugs studied
Dan SotirescuEphrata Cancer Center4 years of reported clinical research
Studies Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
28 drugs studied
Joseph KannarkattWellSpan Medical Oncology and Hematology3 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
7 reported clinical trials
31 drugs studied
Clinical Trials running at WellSpan Health-York Cancer Center
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Small Cell Lung Cancer
Cancer
Lung Carcinoma
Pancreatic Cancer
Recurrence
Prostate Adenocarcinoma
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at WellSpan Health-York Cancer Center?
WellSpan Health-York Cancer Center is a medical facility located in York, Pennsylvania. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. WellSpan Health-York Cancer Center is involved with conducting 129 clinical trials across 170 conditions. There are 9 research doctors associated with this hospital, such as Chanh T. Huynh, Amit B. Shah, Dan Sotirescu, and Joseph Kannarkatt.